These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7095919)
1. Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement. Lowance DC; Murad F; Darrow WR; Bonus L Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):204-8. PubMed ID: 7095919 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet. Tannen RL; Cordano A J Pharmacol Exp Ther; 1978 Jan; 204(1):240-6. PubMed ID: 304099 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
4. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
5. [Biological availability of potassium from a sustained release preparation]. Müller A; Thoma M; Renker H Schweiz Med Wochenschr; 1976 Jan; 106(1):27-30. PubMed ID: 1251146 [TBL] [Abstract][Full Text] [Related]
6. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects. Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463 [TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers. Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748 [TBL] [Abstract][Full Text] [Related]
8. Ulceration of the small intestine due to slow-release potassium chloride tablets. Leijonmarck CE; Räf L Acta Chir Scand; 1985; 151(3):273-8. PubMed ID: 4013604 [TBL] [Abstract][Full Text] [Related]
9. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs]. Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793 [TBL] [Abstract][Full Text] [Related]
10. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability. Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers. Bareggi SR; Gambaro V; Valenti M; Benvenuti C Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373 [TBL] [Abstract][Full Text] [Related]
12. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses. Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
14. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system. González MA; Straughan AB Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability and pharmacokinetics of a new, slow-release potassium chloride capsule. Arnold J; Jacob JT; Riley B J Pharm Sci; 1980 Dec; 69(12):1416-8. PubMed ID: 7463329 [TBL] [Abstract][Full Text] [Related]
16. [Relative bioavailability of effervescent tablet of potassium chloride in healthy volunteers]. Ma YM; Qiu FR; Mao GG; Zeng ZH; Chen B; Sun H Yao Xue Xue Bao; 2001 Sep; 36(9):699-702. PubMed ID: 12580112 [TBL] [Abstract][Full Text] [Related]